The purpose of this study is to evaluate the effects of ABBV-927, which is an investigational immunotherapy drug to be used by researchers for the treatment of all solid tumors. The study also aims to determine the best dose of the drug to use in future trials. ABBV-927 is a protein called a monoclonal antibody, which is intended to help the immune system find, target and kill cancer cells.